Can caregivers independently rate cognitive and behavioral symptoms in Alzheimer's disease patients? A longitudinal analysis

American Journal of Geriatric Psychiatry

Volumn 7, Issue 4, 1999, Pages 321-330

  Ippen, Chandra Ghosh ^a   Olin, Jason T ^a   Schneider, Lon S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; CAREGIVER; COGNITIVE DEFECT; DEMENTIA; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; RATING SCALE; SYMPTOMATOLOGY;

EID: 0032834645     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-199911000-00008     Document Type: Article

References (31)

1. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141:1356-1364
2. Schneider LS, Olin JT, Doody RS, et al: Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. Alzheimer Dis Assoc Disord 1997; 11(suppl 2):S22-S32
3. Rogers SL, Doody RS, Mohs RC, et al: Donepezil improves cognition and global function in Alzheimer's disease. Arch Intern Med 1998; 158:1021-1031
4. Tariot PN, Mack JL, Patterson MR, et al: The Behavior Rating Scale of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995; 152:1349-1357
5. Galasko D, Bennett D, Sano M, et al: An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. Alzheimer Dis Assoc Disord 1997; 11:33-39
6. Farlow M, Gracon SI, Hershey LA, et al: A controlled trial of tacrine in Alzheimer's disease. JAMA 1992; 288:2523-2529
7. Knapp MJ, Knopman DS, Solomon PR, et al: A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271:985-991
8. Antuono PG: Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled study. Arch Intern Med 1995; 155:1766-1772
9. Freedman M, Rewilak D, Xerri T, et al: L-deprenyl in Alzheimer's disease: cognitive and behavioral effects. Neurology 1998; 50:660-668
10. Le Bars PL, Katz MM, Herman N, et al: A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia: North American EGb Study Group. JAMA 1997; 278:1327-1332
11. Koss E, Patterson MB, Ownby R, et al: Memory evaluation in Alzheimer's disease: caregivers' appraisals and objective testing. Arch Neurol 1993; 50:92-97
12. Molloy DW, McLlroy WE, Guyatt GU, et al: Validity and reliability of the dysfunctional behavior rating instrument. Acta Psychiatr Scand 1991; 84:103-106
13. Burns A, Folstein S, Brandt J, et al: Clinical assessment of irritability, aggression, and apathy in Huntington's and Alzheimer's disease. J Nerv Ment Dis 1990; 178:20-26
14. Ferris SH, Mackell JA, Mohs R, et al: A multicenter evaluation of new treatment efficacy instruments for AD clinical trials: overview and general results. Alzheimer Dis Assoc Disorcl 1997; 11:S1-S12
15. Reifler BV, Cox GD, Hanley RJ: Problems of mentally ill elderly as perceived by patients, families, and clinicians. Gerontologist 1981; 21:165-170
16. O'Connor DW, Pollitt PA, Brook CPB, et al: The validity of informant histories in a community study of dementia. Int J Geriatr Psychiatry 1989; 4:203-208
17. Morales J, Gonzalez-Montalvo J, Bermejo F, et al: The screening of mild dementia with a shortened Spanish version of the Informant Questionnaire on Cognitive Decline in the Elderly. Alzheimer Dis Assoc Disord 1995; 9:105-111
18. Morris JC, McKeel DW, Storandt M, et al: Very mild Alzheimer's disease: Informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991; 41:469-478
19. Raskin A, Crook T: Relative's Assessment of Global Symptomatology (RAGS). Psychopharmacol Bull 1988; 24:759-763
20. Doraiswamy PM, Bieber F, Kaiser L, et al: The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials. Neurology 1997; 48:1511-1517
21. DeBettignies BH, Mahurin RK, Pirozzolo FJ: Functional status in Alzheimer's disease and multi-infarct dementia: a comparison of patient performance and caregiver report. Clinical Gerontologist 1993; 12:31-49
22. LaRue A, Watson J, Plotkin DA: Retrospective accounts of dementia symptoms: are they reliable? Gerontologist 1992; 32:240-245
23. Mangone CA, Sanguinetti RM, Baumann PD, et al: Influence of feelings of burden on the caregiver's perception of the patient's functional status. Dementia 1993; 4:287-293
24. McGlone J, Gupta S, Humphrey D, et al: Screening for early dementia using memory complaints from patients and relatives. Arch Neurol 1990; 47:1189-1193
25. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1994; 34:939-944
26. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
27. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141:1356-1364
28. Olin JT, Schneider LS: Assessing response to tacrine using the factor-analytic structure of the Alzheimer's Disease Assessment Scale (ADAS) cognitive subscale. Int J Geriatr Psychiatry 1995; 10:753-756
29. Catell RB: The Scientific Use of Factor Analysis in Behavioral and Life Sciences. New York, Plenum, 1978
30. Teri L, Truax P, Logsdon R, et al: Assessment of behavior problems in dementia: the revised memory and behavior problems checklist. Psychol Aging 1992; 7:622-631
31. Stern RG, Mohs RC, Davidson M, et al: A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. AmJ Psychiatry 1994; 151:390-396